Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
- This year (1)
- Last 5 years (1)
- Last 10 years (1)
Journals and Conferences
BACKGROUND/AIM Several studies have indicated that there are certain predictive factors (gender, duration of infection with HCV, cirrhosis and genotype of HCV) of a better response with… (More)
OBJECTIVES Cisplatin constitutes one of the most potent antineoplastic drugs; however, nephrotoxicity limited its eligibility for optimal clinical use. This study was designed to evaluate the role of… (More)